Evaluation of effectiveness of different dosage neostigmine in combination with metoclopramide on gastric residual volume

Phase 2

• Conditions: dilatation of volume.; Acute dilatation of stomach; K31.0

• Registration Number: IRCT20160523028008N21
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 132

Inclusion Criteria

Age between 20 and 60 years tube
Patients under mechanical ventilation Patients with enteral nutrition through nasogastric

Exclusion Criteria

Previous use of beta-blockers
Heart Block
Bradycardia heart rate less than 60)before inclusion
Hypothermia in the form of central temperature below 35 degrees
Kidney Failure (CR> 1.5) Extra
Recent surgery on stomach or digestive tract within the last ten days
Signs and symptoms of bowel obstruction
Pregnancy and lactation Active
Sensitivity to Neostigmine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gastric residual volume. Timepoint: Before starting the drug infusion and 3, 6, 9 and 12 hours after the start of the infusion. Method of measurement: Aspirate with a gavage syringe.